277 related articles for article (PubMed ID: 22419664)
1. Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma.
Coulouarn C; Corlu A; Glaise D; Guénon I; Thorgeirsson SS; Clément B
Cancer Res; 2012 May; 72(10):2533-42. PubMed ID: 22419664
[TBL] [Abstract][Full Text] [Related]
2. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
[TBL] [Abstract][Full Text] [Related]
4. Cluster of differentiation 147 is a key molecule during hepatocellular carcinoma cell-hepatic stellate cell cross-talk in the rat liver.
Ma T; Wang Z; Yang Z; Chen J
Mol Med Rep; 2015 Jul; 12(1):111-8. PubMed ID: 25738354
[TBL] [Abstract][Full Text] [Related]
5. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma.
Ji J; Eggert T; Budhu A; Forgues M; Takai A; Dang H; Ye Q; Lee JS; Kim JH; Greten TF; Wang XW
Hepatology; 2015 Aug; 62(2):481-95. PubMed ID: 25833323
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
7. CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression.
Makino Y; Hikita H; Kodama T; Shigekawa M; Yamada R; Sakamori R; Eguchi H; Morii E; Yokoi H; Mukoyama M; Hiroshi S; Tatsumi T; Takehara T
Cancer Res; 2018 Sep; 78(17):4902-4914. PubMed ID: 29967264
[TBL] [Abstract][Full Text] [Related]
8. Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1.
Lin N; Meng L; Lin J; Chen S; Zhang P; Chen Q; Lin Y
J Cell Biochem; 2020 Feb; 121(2):1441-1451. PubMed ID: 31609020
[TBL] [Abstract][Full Text] [Related]
9. Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production.
Myojin Y; Hikita H; Sugiyama M; Sasaki Y; Fukumoto K; Sakane S; Makino Y; Takemura N; Yamada R; Shigekawa M; Kodama T; Sakamori R; Kobayashi S; Tatsumi T; Suemizu H; Eguchi H; Kokudo N; Mizokami M; Takehara T
Gastroenterology; 2021 Apr; 160(5):1741-1754.e16. PubMed ID: 33346004
[TBL] [Abstract][Full Text] [Related]
10. CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.
Li ZQ; Wu WR; Zhao C; Zhao C; Zhang XL; Yang Z; Pan J; Si WK
Int J Mol Med; 2018 Mar; 41(3):1518-1528. PubMed ID: 29286082
[TBL] [Abstract][Full Text] [Related]
11. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
[TBL] [Abstract][Full Text] [Related]
12. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
[TBL] [Abstract][Full Text] [Related]
13. Rat hepatic stellate cells alter the gene expression profile and promote the growth, migration and invasion of hepatocellular carcinoma cells.
Wang ZM; Zhou LY; Liu BB; Jia QA; Dong YY; Xia YH; Ye SL
Mol Med Rep; 2014 Oct; 10(4):1725-33. PubMed ID: 25109274
[TBL] [Abstract][Full Text] [Related]
14. Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells.
Sancho-Bru P; Juez E; Moreno M; Khurdayan V; Morales-Ruiz M; Colmenero J; Arroyo V; Brenner DA; Ginès P; Bataller R
Liver Int; 2010 Jan; 30(1):31-41. PubMed ID: 19929904
[TBL] [Abstract][Full Text] [Related]
15. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway.
Zhang R; Gao X; Zuo J; Hu B; Yang J; Zhao J; Chen J
Cancer Sci; 2020 Feb; 111(2):406-417. PubMed ID: 31785057
[TBL] [Abstract][Full Text] [Related]
16. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
[TBL] [Abstract][Full Text] [Related]
17. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma.
Wang PW; Lin TY; Yang PM; Yeh CT; Pan TL
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142683
[TBL] [Abstract][Full Text] [Related]
19. Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma.
Liao R; Sun TW; Yi Y; Wu H; Li YW; Wang JX; Zhou J; Shi YH; Cheng YF; Qiu SJ; Fan J
Cancer Sci; 2012 Jun; 103(6):984-92. PubMed ID: 22417086
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells.
Shen H; Yu H; Li QY; Wei YT; Fu J; Dong H; Cao D; Guo LN; Chen L; Yang Y; Xu Y; Wu MC; Wang HY; Chen Y
Acta Pharmacol Sin; 2022 Nov; 43(11):2917-2928. PubMed ID: 35508720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
